Work

SWOG 1609 (DART): A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps2658

Authors: Sandip Pravin Patel, Megan Othus, Young Kwang Chae, Frank Giles, Jourdain Hayward, Christine McLeod, Helen X. Chen, Elad Sharon, Edward Mayerson, Christopher W. Ryan, Melissa Plets, Charles David Blanke, Razelle Kurzrock

Institutions: University of California San Diego, Moores Cancer Center, Fred Hutch Cancer Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, National Cancer Institute, OHSU Knight Cancer Institute, Oregon Health & Science University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947947780

Cites:

Cited by: 15

Related to: 10